leisure time -WSS

leisure time

author：explore 2025-09-28 03:50:52 - browse：8574

Warning sign illustration made of 0s and 1s. -- first opinion coverage from sTAT — Adobe

Big businesses poised to profit from the advance of artificial intelligence in health care are pushing back against newly proposed federal rules meant to increase oversight and fairness of AI tools used to help make decisions about patient care.

The opposition, which includes Google and Amazon as well as large health care providers, insurers, and medical software vendors, is focused on an attempt to put tighter guardrails around the use of AI by the Office of the National Coordinator for Health Information Technology.

The agency wants to require developers of electronic health records and other health software to provide users with details about the training and testing of predictive models that draw data from their systems, or are hosted within them. It also wants developers to assess and publicly disclose potential risks and create a way for clinicians and other users to report problems.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Moonlake's readout produced a cash windfall. Risks remain
Next article： Why depression after traumatic brain injury is distinct

hotspot

WSS

NIH study of ME/CFS points to clear biological hallmarks

Alabama frozen embryo ruling has major implications for IVF clinics

UCLA team creates talking throat patch for voice disorders

RaDonda Vaught links Vanderbilt hospital issues to patient death

Readout Newsletter: CAR

Readout Newsletter: Alnylam, Celldex, Roche, Zealand Pharma

knowledge

leisure time

knowledge

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

STAT readers on older presidents, polypills, Medicare, and more

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

President Biden's budget: Here's what you might have missed

Tori Bowie and the unacceptable rates of Black maternal death

Why scientists need input from humanists on sensitive research

Sports medicine is finally prioritizing gender equality

Cyberattack on UnitedHealth subsidiary cripples pharmacies, hospitals

Walensky prepares to leave CDC — and Congress — behind

First U.S. drug developed to treat liver disease MASH is approved

leisure time

RaDonda Vaught links Vanderbilt hospital issues to patient death

Amid AI frenzy, a top HHS official's quest to create safeguards

In boost for rare disease push, AstraZeneca to buy Amolyt Pharma

Annovis Bio delivers candor, but not confidence, on Parkinson’s study

How to save health care price transparency rules

UCLA team creates talking throat patch for voice disorders

focus

hotspot

entertainment

focus